Mark E. Hatley

Affiliations: 
St. Jude Children’s Research Hospital, USA 
Area:
pediatric cancer, sarcoma, muscle
Google:
"Mark Hatley"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Searcy MB, Larsen RK, Stevens BT, et al. (2023) PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors. Nature Communications. 14: 7291
Singh S, Abu-Zaid A, Jin H, et al. (2022) Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma. Science Translational Medicine. 14: eabq2096
Hanna JA, Langdon CG, Garcia MR, et al. (2022) Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2-Cre mice. The Journal of Pathology
Langdon CG, Hatley ME. (2021) The perfect PTEN - transcriptional regulation by PTEN dictates sarcoma identity. Molecular & Cellular Oncology. 8: 2002120
Langdon CG, Gadek KE, Garcia MR, et al. (2021) Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity. Nature Communications. 12: 5520
Drummond CJ, Hatley ME. (2018) A Case of mistaken identity: Rhabdomyosarcoma development from endothelial progenitor cells. Molecular & Cellular Oncology. 5: e1448246
Hanna JA, Garcia MR, Lardennois A, et al. (2018) PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. Oncogene
Drummond CJ, Hanna JA, Garcia MR, et al. (2018) Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors. Cancer Cell. 33: 108-124.e5
Hanna JA, Drummond CJ, Garcia MR, et al. (2017) Biallelic Dicer1 loss mediated by aP2-Cre drives angiosarcoma. Cancer Research
Chen X, Stewart E, Shelat AA, et al. (2013) Targeting oxidative stress in embryonal rhabdomyosarcoma. Cancer Cell. 24: 710-24
See more...